SEC Form 4 · accession 0001437749-18-001144
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Durbin
Officer — Chief Financial Officer
Period of report
Jan 23, 2018
Accepted (ET)
Jan 25, 2018 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Purchase)F1 | $4.48 | Jan 23, 2018 | A | 120,000 | A | — | Jan 22, 2028 | Common Stock | 120,000 | 120,000 | D |
Explanation of responses
- F1The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 120,000 incentive stock options on January 23, 2018 (the "Grant Date"). The incentive stock options will vest in equal monthly increments over 48 months following the Grant Date.